I too thought that HER2 predicts benefit from adjuvant paclitaxel after AC in node-positive breast cance specifically. However, there are no evidence based studies to to verify that taxanes would benefit nodes negatives or scantly micrometastatic nodes.
__________________
Robin
2002- dx her2 positive DCIS/bc TX Mast, herceptin chemo
|